Publications
-
Feasibility of Community-Based careHPV for Cervical Cancer Prevention in Rural Thailand.
Trope LA,
Chumworathayi B, Blumenthal PD.
J Low Genit Tract Dis.
2013
-
Revitalizing long-acting reversible contraceptives in settings with high unmet need: a multicountry experience matching demand creation and service delivery.
Blumenthal PD,
Shah NM, Jain K, Saunders A, Clemente C, Lucas B, Jafa K, Eber M.
Contraception.
2013;
87
(2):
170-5
-
Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up.
Lynd K,
Blum J, Ngoc NT, Shochet T, Blumenthal PD, Winikoff B.
Int J Gynaecol Obstet.
2013;
121
(2):
144-8
-
Efficacy, safety, acceptability and affordability of cryotherapy: a review of current literature.
McClung EC,
Blumenthal PD.
Minerva Ginecol.
2012;
64
(2):
149-71
-
Factors Influencing Women's Decision to Seek Antenatal Care in the ANDES of Peru.
Huaman Ayala LS,
Blumenthal PD, Sarnquist CC.
Matern Child Health J.
2012
-
Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.
Blumenthal PD,
Voedisch A, Gemzell-Danielsson K.
Hum Reprod Update.
2011 Jan-Feb;
17
(1):
121-37
-
Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system.
Blumenthal PD,
Dawson L, Hurskainen R.
Int J Gynaecol Obstet.
2011;
112
(3):
171-8
-
Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
Rahangdale L,
Sarnquist C, Yavari A, Blumenthal P, Israelski D.
J Womens Health (Larchmt).
2010;
19
(4):
709-12
-
Preventing cervical cancer: stakeholder attitudes toward CareHPV-focused screening programs in Roi-et Province, Thailand.
Trope LA,
Chumworathayi B, Blumenthal PD.
Int J Gynecol Cancer.
2009;
19
(8):
1432-8
-
Rates of serious infection after medical abortion.
Kapp N,
Winikoff B, Blumenthal PD.
N Engl J Med.
2009;
361
(15):
1511-2; author reply 1512
-
The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability.
Beatty MN,
Blumenthal PD.
Ther Clin Risk Manag.
2009;
5
(3):
561-74
-
Hormonal contraception.
Blumenthal PD,
Edelman A.
Obstet Gynecol.
2008;
112
(3):
670-84
-
Tolerability and clinical safety of Implanon.
Blumenthal PD,
Gemzell-Danielsson K, Marintcheva-Petrova M.
Eur J Contracept Reprod Health Care.
2008:
13 Suppl 1
29-36
-
A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding.
Liu Z,
Doan QV, Blumenthal P, Dubois RW.
Value Health.
2007 May-Jun;
10
(3):
183-94
-
Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana.
Blumenthal PD,
Gaffikin L, Deganus S, Lewis R, Emerson M, Adadevoh S.
Am J Obstet Gynecol.
2007;
196
(4):
407.e1-8; discussion 407.e8-9
-
Family planning: a cornerstone for public health and sustainable development.
Blumenthal PD,
Gaffikin L.
MedGenMed.
2007;
9
(4):
16
-
The supreme court and the Partial-Birth Abortion Ban Act of 2003: a political procedure replaces woman-centered care.
Blumenthal PD,
Winikoff B.
MedGenMed.
2007;
9
(2):
52
-
Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception.
Blumenthal PD,
Trussell J, Singh RH, Guo A, Borenstein J, Dubois RW, Liu Z.
Contraception.
2006;
74
(3):
249-58
-
Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol.
Castleman LD,
Oanh KT, Hyman AG, Thuy le T, Blumenthal PD.
Contraception.
2006;
74
(3):
272-6
-
Letter from Madagascar.
Blumenthal PD,
Obstet Gynecol.
2006;
108
(3 Pt 1):
684-6
-
Mortality associated with mifepristone-misoprostol medical abortion.
Creinin M,
Blumenthal P, Shulman L.
MedGenMed.
2006;
8
(2):
26
-
Cervical cancer prevention: making programs more appropriate and pragmatic.
Blumenthal PD,
Gaffikin L.
JAMA.
2005;
294
(17):
2225-8
-
Digital camera assessment for detection of cervical intraepithelial neoplasia in rural El Salvador.
Cremer M,
Jamshidi RM, Muderspach L, Tsao-Wei D, Felix JC, Blumenthal PD.
Int J Gynaecol Obstet.
2005;
91
(1):
42-6
-
Hormonal management of abnormal uterine bleeding.
Singh RH,
Blumenthal P.
Clin Obstet Gynecol.
2005;
48
(2):
337-52
-
Multicenter trial of a simplified mifepristone medical abortion regimen.
Shannon CS,
Winikoff B, Hausknecht R, Schaff E, Blumenthal PD, Oyer D, Sankey H, Wolff J, Goldberg R.
Obstet Gynecol.
2005;
105
(2):
345-51
-
Postpartum contraception: the New Mexico Pregnancy Risk Assessment Monitoring System.
Depiñeres T,
Blumenthal PD, Diener-West M.
Contraception.
2005;
72
(6):
422-5
-
Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy.
Blumenthal PD,
Lauterbach M, Sellors JW, Sankaranarayanan R.
Int J Gynaecol Obstet.
2005:
89 Suppl 2
S30-7
-
A consensus regimen for early abortion with misoprostol.
Philip NM,
Winikoff B, Moore K, Blumenthal P.
Int J Gynaecol Obstet.
2004;
87
(3):
281-3
-
Are partners available for post-abortion contraceptive counseling? A pilot study in a Baltimore City clinic.
Beenhakker B,
Becker S, Hires S, Molano Di Targiana N, Blumenthal P, Huggins G.
Contraception.
2004;
69
(5):
419-23
-
Digital assessment of the reproductive tract (DART).
Jamshidi R,
Blumenthal P.
J Acquir Immune Defic Syndr.
2004:
37 Suppl 3
S171-3
-
Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections.
Morrison CS,
Bright P, Wong EL, Kwok C, Yacobson I, Gaydos CA, Tucker HT, Blumenthal PD.
Sex Transm Dis.
2004;
31
(9):
561-7
-
Oral contraceptives and cervical cancer: critique of a recent review.
Miller K,
Blumenthal P, Blanchard K.
Contraception.
2004;
69
(5):
347-51
-
Sensitive methods to detect epithelial disruption: tests for microhemorrhage in cervicovaginal lavages.
Moench T,
Mehrazar K, Cone R, Blumenthal P.
J Acquir Immune Defic Syndr.
2004:
37 Suppl 3
S194-200
-
Manual vacuum aspiration for second-trimester pregnancy termination.
Todd CS,
Soler ME, Castleman L, Rogers MK, Blumenthal PD.
Int J Gynaecol Obstet.
2003;
83
(1):
5-9
-
More on science and politics.
Bass GD,
Blumenthal PD, Corfman P, Darney PD, Gonsalves G, Levin AA, Trussell J, Shields WC.
Science.
2003;
299
(5611):
1313
-
Performance of visual inspection with acetic acid for cervical cancer screening: a qualitative summary of evidence to date.
Gaffikin L,
Lauterbach M, Blumenthal PD.
Obstet Gynecol Surv.
2003;
58
(8):
543-50
-
Risk factors as the basis for triage in low-resource cervical cancer screening programs.
Gaffikin L,
Ahmed S, Chen YQ, McGrath JM, Blumenthal PD.
Int J Gynaecol Obstet.
2003;
80
(1):
41-7
-
Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project.
Gaffikin L,
Blumenthal PD, Emerson M, Limpaphayom K.
Lancet.
2003;
361
(9360):
814-20
-
Similarities in women's perceptions and acceptability of manual vacuum aspiration and electric vacuum aspiration for first trimester abortion.
Bird ST,
Harvey SM, Beckman LJ, Nichols MD, Rogers K, Blumenthal PD.
Contraception.
2003;
67
(3):
207-12
-
The federal ban on so-called "partial-birth abortion" is a dangerous intrusion into medical practice.
Blumenthal PD,
MedGenMed.
2003;
5
(2):
37
-
Mifepristone at one year: a forward look back.
Burke AE,
Moore K, Blumenthal PD.
Medscape Womens Health.
2002 Mar-Apr;
7
(2):
1
-
Reflections on the WHI findings: avoiding a pill scare and taking sensible steps forward.
Blumenthal PD,
Medscape Womens Health.
2002 Jul-Aug;
7
(4):
6
-
A revolution in cervical screening.
Blumenthal PD,
Gaffikin L, McInstosh N.
BJOG.
2002;
109
(12):
1417-8
-
Assessment of the cervix after acetic acid wash: inter-rater agreement using photographs.
Sellors JW,
Jeronimo J, Sankaranarayanan R, Wright TC, Howard M, Blumenthal PD.
Obstet Gynecol.
2002;
99
(4):
635-40
-
Buccal misoprostol as cervical preparation for second trimester pregnancy termination.
Todd CS,
Soler M, Castleman L, Rogers MK, Blumenthal PD.
Contraception.
2002;
65
(6):
415-8
-
Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
Mandelblatt JS,
Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.
J Natl Cancer Inst.
2002;
94
(19):
1469-83
-
Edward J. Haupt (1936-2001).
Blumenthal PE,
Blumenthal AL.
Hist Psychol.
2002;
5
(2):
207-9
-
The Filshie clip for laparoscopic adnexal surgery.
Garcia FA,
Barker B, Myloyde T, Blumenthal P, Huggins GR.
JSLS.
2001 Apr-Jun;
5
(2):
179-81
-
Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear.
Blumenthal PD,
Gaffikin L, Chirenje ZM, McGrath J, Womack S, Shah K.
Int J Gynaecol Obstet.
2001;
72
(1):
47-53
-
Computerized planimetry versus clinical assessment for the measurement of cervical ectopia.
Morrison CS,
Bright P, Blumenthal PD, Yacobson I, Kwok C, Zdenek S, Pan Z.
Am J Obstet Gynecol.
2001;
184
(6):
1170-6
-
Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro.
Shamblott MJ,
Axelman J, Littlefield JW, Blumenthal PD, Huggins GR, Cui Y, Cheng L, Gearhart JD.
Proc Natl Acad Sci U S A.
2001;
98
(1):
113-8
-
Innovative approaches to cervical cancer prevention.
Blumenthal PD,
Ringers P, McIntosh N, Gaffikin L.
Medscape Womens Health.
2001;
6
(6):
1
-
Successful use of oral contraceptives.
Burke AE,
Blumenthal PD.
Semin Reprod Med.
2001;
19
(4):
313-21
-
The approval of mifepristone (RU486) in the United States: What's wrong with this picture?
Blumenthal P,
Johnson J, Stewart F.
Medscape Womens Health.
2000 Jul-Aug;
5
(4):
E7
-
Cervical cancer screening in developing countries.
Soler ME,
Gaffikin L, Blumenthal PD.
Prim Care Update Ob Gyns.
2000;
7
(3):
118-123
-
Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe.
Womack SD,
Chirenje ZM, Blumenthal PD, Gaffikin L, McGrath JA, Chipato T, Ngwalle E, Shah KV.
BJOG.
2000;
107
(1):
33-8
-
HPV-based cervical cancer screening in a population at high risk for HIV infection.
Womack SD,
Chirenje ZM, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV.
Int J Cancer.
2000;
85
(2):
206-10
-
New technologies in cervical cancer precursor detection.
Soler ME,
Blumenthal PD.
Curr Opin Oncol.
2000;
12
(5):
460-5
-
The "boom and bust phenomenon": the hopes, dreams, and broken promises of the contraceptive revolution.
Boonstra H,
Duran V, Northington Gamble V, Blumenthal P, Dominguez L, Pies C.
Contraception.
2000;
61
(1):
9-25
-
The Filshie clip in nonsterilization gynecologic laparoscopy.
Garcia FA,
Barker B, Myloyde T, Blumenthal P.
Obstet Gynecol.
2000;
96
(5 Pt 2):
848
-
Timing of onset of contraceptive effectiveness in Norplant implant users. II. Effect on the ovarian function in the first cycle of use.
Brache V,
Blumenthal PD, Alvarez F, Dunson TR, Cochon L, Faundes A.
Contraception.
1999;
59
(4):
245-51
-
Derivation of pluripotent stem cells from cultured human primordial germ cells.
Shamblott MJ,
Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD, Huggins GR, Gearhart JD.
Proc Natl Acad Sci U S A.
1998;
95
(23):
13726-31
-
Developments in contraception: a comprehensive review of Desogen (desogestrel and ethinyl estradiol).
Lammers P,
Blumenthal PD, Huggins GR.
Contraception.
1998;
57
(5 Suppl):
1S-27S
-
Provider attitudes toward IUD provision in Zimbabwe: perception of HIV risk and training implications.
Gaffikin L,
Phiri A, McGrath J, Zinanga A, Blumenthal PD.
Adv Contracept.
1998;
14
(1):
27-39
-
Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus.
Dunson TR,
Blumenthal PD, Alvarez F, Brache V, Cochon L, Dalberth B, Glover L, Remsburg R, Vu K, Katz D.
Fertil Steril.
1998;
69
(2):
258-66
-
Ulnar nerve injury associated with removal of Norplant implants.
Smith JM,
Conwit RA, Blumenthal PD.
Contraception.
1998;
57
(2):
99-101
-
Training for Norplant implant removal: assessment of learning curves and competency.
Blumenthal PD,
Gaffikin L, Garrikin L, Affandi B, Bongiovanni A, McGrath J, Glew G.
Obstet Gynecol.
1997;
89
(2):
174-8
-
Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide.
Mauck C,
Glover LH, Miller E, Allen S, Archer DF, Blumenthal P, Rosenzweig A, Dominik R, Sturgen K, Cooper J, Fingerhut F, Peacock L, Gabelnick HL.
Contraception.
1996;
53
(6):
329-35
-
Laparoscopic sterilization in the supine position using the Ramathibodi uterine manipulator.
Blumenthal PD,
Fertil Steril.
1995;
64
(1):
204-7
-
Usefulness of a clinical scoring system to anticipate difficulty of Norplant removal.
Blumenthal PD,
Remsburg RE, Glew G, McGrath JA, Gaffikin L.
Adv Contracept.
1995;
11
(4):
345-52
-
A time and cost analysis of the management of incomplete abortion with manual vacuum aspiration.
Blumenthal PD,
Remsburg RE.
Int J Gynaecol Obstet.
1994;
45
(3):
261-7
-
Comparison of adolescent and adult experiences with Norplant levonorgestrel contraceptive implants.
Cullins VE,
Remsburg RE, Blumenthal PD, Huggins GR.
Obstet Gynecol.
1994;
83
(6):
1026-32
-
Contraceptive outcomes among post-partum and post-abortal adolescents.
Blumenthal PD,
Wilson LE, Remsburg RE, Cullins VE, Huggins GR.
Contraception.
1994;
50
(5):
451-60
-
Recovery from outpatient laparoscopic tubal ligation is not improved by preoperative administration of ketorolac or ibuprofen.
Higgins MS,
Givogre JL, Marco AP, Blumenthal PD, Furman WR.
Anesth Analg.
1994;
79
(2):
274-80
-
Preliminary experience with Norplant in an inner city population.
Cullins VE,
Blumenthal PD, Remsburg RE, Huggins GR.
Contraception.
1993;
47
(2):
193-203
-
Abortion: epidemiology, safety, and technique.
Blumenthal PD,
Curr Opin Obstet Gynecol.
1992;
4
(4):
506-12
-
Abortion.
Blumenthal PD,
Curr Opin Obstet Gynecol.
1991;
3
(4):
496-500
-
Nonpharmaceutical ripening of the unfavorable cervix and induction of labor by a novel double balloon device.
Blumenthal PD,
Gaffikin L.
Obstet Gynecol.
1991;
77
(6):
967-8
-
Letter from Africa.
Blumenthal PD,
Obstet Gynecol.
1990;
76
(1):
147-8
-
Randomized trial of Dilapan and Laminaria as cervical ripening agents before induction of labor.
Blumenthal PD,
Ramanauskas R.
Obstet Gynecol.
1990;
75
(3 Pt 1):
365-8
-
Comparison of the nipple stimulation and exogenous oxytocin contraction stress tests. A randomized, prospective study.
Rosenzweig BA,
Levy JS, Schipiour P, Blumenthal PD.
J Reprod Med.
1989;
34
(12):
950-4
-
Problem visits to a family planning clinic.
Blumenthal PD,
Jacobson J, Gaffikin L.
J Reprod Med.
1988;
33
(1):
58-62
-
Prospective comparison of Dilapan and laminaria for pretreatment of the cervix in second-trimester induction abortion.
Blumenthal PD,
Obstet Gynecol.
1988;
72
(2):
243-6
-
The prophylactic effect of doxycycline on postoperative infection rate after first-trimester abortion.
Blumenthal PD,
Rosenzweig BA.
Obstet Gynecol.
1988;
72
(1):
146
-
Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program.
Scoccia B,
Blumenthal P, Wagner C, Prins G, Scommegna A, Marut EL.
Fertil Steril.
1987;
48
(3):
446-9
-
Comparison of uterine activity induced by nipple stimulation and oxytocin.
Levy J,
Rosenzweig B, Blumenthal P.
Obstet Gynecol.
1987;
70
(3 Pt 1):
430-2
-
Ethnicity and hip fracture.
Blumenthal PD,
Marut E, Gaffikin L.
Am J Public Health.
1987;
77
(3):
369
-
Amnioinfusion for fetal distress.
Levy J,
Rosenzweig B, Blumenthal PD.
Am J Obstet Gynecol.
1986;
155
(6):
1361
Navigation for This Section: Obstetrics & Gynecology
Additinal Links: Clinical Divisions
Additinal Links: Centers
Additinal Links: Consortiums
Find a Researcher
Help